Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Basso

Showing results (331-340 of 379) with videos related to

Pageof 38
Sort By:
British Journal of Haematology|February 27, 2015
Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohortMaria L Randi, Giulia Geranio, Irene Bertozzi, et al.
Leukemia|June 14, 2020
Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocolsAlexander Popov, Barbara Buldini, Paola De Lorenzo, et al.
The Lancet. Haematology|February 9, 2016
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysisValentino Conter, Maria Grazia Valsecchi, Barbara Buldini, et al.
Oncotarget|November 18, 2015
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signalingLaura Mediani, Federica Gibellini, Jessika Bertacchini, et al.
Plos One|January 30, 2013
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro studyDaniela Basso, Paola Fogar, Massimo Falconi, et al.
The Journal of Molecular Diagnostics : JMD|March 7, 2020
Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic LeukemiaRoberta La Starza, Valentina Pierini, Tiziana Pierini, et al.
Nature|January 18, 2018
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemiaGannie Tzoneva, Chelsea L Dieck, Koichi Oshima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study GroupTorsten Haferlach, Alexander Kohlmann, Lothar Wieczorek, et al.
Haematologica|May 30, 2013
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohortsSabina Chiaretti, Antonella Vitale, Gianni Cazzaniga, et al.
Blood|January 14, 2014
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 studyValentino Conter, Maria Grazia Valsecchi, Rosanna Parasole, et al.
Pageof 38

Showing results (331-340 of 379) with videos related to

Sort By:
Pageof 38
British Journal of Haematology|February 27, 2015
Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohortMaria L Randi, Giulia Geranio, Irene Bertozzi, et al.
Leukemia|June 14, 2020
Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocolsAlexander Popov, Barbara Buldini, Paola De Lorenzo, et al.
The Lancet. Haematology|February 9, 2016
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysisValentino Conter, Maria Grazia Valsecchi, Barbara Buldini, et al.
Oncotarget|November 18, 2015
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signalingLaura Mediani, Federica Gibellini, Jessika Bertacchini, et al.
Plos One|January 30, 2013
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro studyDaniela Basso, Paola Fogar, Massimo Falconi, et al.
The Journal of Molecular Diagnostics : JMD|March 7, 2020
Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic LeukemiaRoberta La Starza, Valentina Pierini, Tiziana Pierini, et al.
Nature|January 18, 2018
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemiaGannie Tzoneva, Chelsea L Dieck, Koichi Oshima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study GroupTorsten Haferlach, Alexander Kohlmann, Lothar Wieczorek, et al.
Haematologica|May 30, 2013
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohortsSabina Chiaretti, Antonella Vitale, Gianni Cazzaniga, et al.
Blood|January 14, 2014
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 studyValentino Conter, Maria Grazia Valsecchi, Rosanna Parasole, et al.
Pageof 38